Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
GenSpera, Inc. Identifier:
First received: January 25, 2010
Last updated: February 16, 2014
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)